Tae Park Sang
Directeur/Bestuurslid bij Oxford Cancer Biomarkers Ltd.
Profiel
Tae Park Sang is a Non-Executive Director at Oxford Cancer Biomarkers Ltd.
He was previously the Chief Executive Officer at Dx & Vx Co., Ltd.
Actieve functies van Tae Park Sang
| Bedrijven | Functie | Begin |
|---|---|---|
Oxford Cancer Biomarkers Ltd.
 Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Tae Park Sang
| Bedrijven | Functie | Einde |
|---|---|---|
| DX & VX CO., LTD. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DX & VX CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Health Services |
